Regenosine, Inc.

Princeton, NJ

UEI
G2MDS89Q9BG5
CAGE
87QM9
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
303a College Rd E, Princeton, NJ 08540, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Regenosine, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy - abstract… Grant · SB1AR084381 National Insititue of Arthritis and Musculoskeletal and Skin Diseases $797,793
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy - abstract… Grant · R44AR078691 National Insititue of Arthritis and Musculoskeletal and Skin Diseases $2,483,194

Quick answers

What is Regenosine, Inc.'s UEI?

Regenosine, Inc.'s Unique Entity ID (UEI) in SAM.gov is G2MDS89Q9BG5.

What is Regenosine, Inc.'s CAGE code?

Regenosine, Inc.'s CAGE code is 87QM9.

What is Regenosine, Inc.'s primary NAICS code?

Regenosine, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Regenosine, Inc. located?

Regenosine, Inc.'s physical address in SAM.gov is 303a College Rd E, Princeton, NJ 08540, USA.

Is Regenosine, Inc. registered in SAM.gov?

Yes. Regenosine, Inc.'s SAM.gov registration is active through July 15, 2027.

What is Regenosine, Inc.'s most recent federal award?

Regenosine, Inc.'s most recent federal grant award is Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy - abstract… (SB1AR084381), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on August 5, 2024.

On GovTribe

See Regenosine, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login